Acute and nine-month clinical outcomes after 'suboptimal' coronary stenting: Results from the STent Anti-thrombotic Regimen Study (STARS) registry

Journal of the American College of Cardiology

Volumn 34, Issue 3, 1999, Pages 698-706

  Cutlip, Donald E ^a   Leon, Martin B ^b   Ho, Kalon K L ^c   Gordon, Paul C ^d   Giambartolomei, Alessandro ^e   Diver, Daniel J ^f   Lasorda, David M ^g   Williams, David O ^h   Fitzpatrick, Michelle M ^c   Desjardin, April ^c   Popma, Jeffrey J ⁱ   Kuntz, Richard E ^c   Baim, Donald S ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d MIRIAM HOSPITAL   (United States)

^e St Joseph's Hospital   (United States)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g ALLEGHENY UNIVERSITY HOSPITALS   (United States)

^h RHODE ISLAND HOSPITAL   (United States)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE DISEASE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY DISEASE; CORONARY THROMBOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RECURRENCE; REGISTRIES; STATISTICS, NONPARAMETRIC; STENTS; TIME FACTORS; UNITED STATES;

EID: 0032869043     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00271-5     Document Type: Article

References (17)

1. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med. 331:1994;496-501.
2. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med. 331:1994;489-495.
3. Serruys P.W., Strauss B.H., Beatt K.J., et al. Angiographic follow-up after placement of a self-expanding coronary-artery stent. N Engl J Med. 324:1991;13-17.
4. Cohen D.J., Krumholz H.M., Sukin C.A., et al. In-hospital and one-year economic outcomes after coronary stenting or balloon angioplasty. Results from a randomized clinical trial. Stent Restenosis Study Investigators. Circulation. 92:1995;2480-2487.
5. Colombo A., Hall P., Nakamura S., et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation. 91:1995;1676-1688.
6. Albiero R., Hall P., Itoh A., et al. Results of a consecutive series of patients receiving only antiplatelet therapy after optimized stent implantation. Circulation. 95:1997;1145-1156.
7. Moussa I., Mario C.D., Reimers B., et al. Subacute stent thrombosis in the era of intravascular ultrasound-guided coronary stenting without anticoagulation frequency, predictors, and clinical outcome . J Am Coll Cardiol. 29:1997;6-12.
8. Schomig A., Neumann F.J., Kastrati A., et al. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 334:1996;1084-1089.
9. Leon M.B., Baim D.S., Popma J., et al. A clinical trial comparing three anti-thrombotic drug regimens following coronary artery stenting. N Engl J Med. 339:1998;1665-1671.
10. SAS. The Logistic Procedure. In: 4th, ed. SAS/STAT User's Guide. Version 6. Vol. 2. Cary, NC: SAS Institute; 1990:1071-134.
11. Cutlip D., Chauhan M., Lasorda D., et al. Influence of post-procedural myocardial infarction on late clinical outcome in the Stent Anti-thrombotic Regimen Study (STARS). (abstr). Circulation. 96:(Suppl I):1997;31.
12. Baim D., Cutlip D., Midei M., et al. Acute 30 day and late clinical events in the randomized parallel-group comparison of the ACS Multi-Link coronary stent system and the Palmaz-Schatz stent. (abstr). Circulation. 96:(Suppl I):1997;593.
13. Serruys P.W., van Hout B., Bonnier H., et al. Randomized comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II). Lancet. 352:1998;673-681.
14. May A.E., Neumann F., Gawaz M., et al. Reduction of monocyte platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent imlantation. European Heart J. 18:1997;1913-1920.
15. Mathew V., Hasdai D., Holmes D.R. Jr, et al. Clinical outcome of patients undergoing endoluminal coronary artery reconstruction with three or more stents. J Am Coll Cardiol. 30:1997;676-681.
16. Kastrati A., Schomig A., Elezi S., et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol. 30:1997;1428-1436.
17. Randomized placebo-controlled and balloon angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 352:1998;87-92.